GNTA
Genenta Science SpA
0.7852$
+10.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
Genenta Science SpA (GNTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 32 million €. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 19 | Q4 19 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q2 24 | Q4 24 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 21 | – | – | 18 | – | 13 | – | 40 | 40 | 38 | 0.0 | 33 | 33 | 27 | 22 | 22 | 19 | 15 | 22 | 32 | 32 | |
| – | 21 | – | 17 | 17 | 12 | 12 | – | 39 | 39 | 37 | 0.0 | 32 | 32 | 25 | 21 | 21 | 19 | 14 | 21 | 30 | 30 | |
| – | 20 | – | – | 15 | – | 11 | – | 37 | 37 | 35 | 0.0 | 30 | 30 | 12 | 3.7 | 3.7 | 6.2 | 4.6 | 5.2 | 5.5 | 5.5 | |
| – | 20 | – | – | 15 | – | 11 | – | 37 | 37 | 35 | 0.0 | 30 | 30 | 22 | 19 | 19 | 17 | 13 | 18 | – | 28 | |
| – | – | – | 0.8 | 0.8 | 1.1 | 1.1 | 1.4 | 1.4 | 1.4 | 1.9 | 1.9 | 1.6 | 1.6 | 1.9 | – | 2.0 | 1.2 | 1.4 | – | – | 1.3 | |
| – | -0.2 | – | – | 0.0 | – | 0.1 | – | 0.1 | 0.1 | 0.7 | 0.7 | 0.1 | 0.1 | 0.4 | – | 0.0 | – | – | – | – | – | |
| – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.1 | 0.1 | – | – | 0.1 | 0.1 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | 0.0 | 0.0 | 0.1 | 0.1 | – | 0.1 | – | – | – | |
| – | 2.5 | – | – | 2.4 | – | 1.7 | – | 1.2 | 1.2 | 1.3 | 0.0 | 2.3 | 2.3 | 1.9 | 1.9 | 1.9 | 2.2 | 2.3 | 9.4 | 10 | 10 | |
| – | 2.5 | – | 2.3 | 2.3 | 1.7 | 1.7 | – | 1.1 | 1.1 | 1.2 | 0.0 | 2.2 | 2.2 | 1.8 | 1.7 | 1.7 | 2.0 | 2.1 | 1.6 | 2.1 | 2.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | 0.0 | – | 0.0 | 0.0 | – | – | – | |
| – | 0.6 | – | 0.6 | 0.6 | 0.4 | 0.4 | – | 0.2 | 0.2 | 0.5 | 0.0 | 1.2 | 1.2 | 0.5 | 0.5 | 0.3 | 0.6 | 0.3 | 1.0 | 1.5 | 1.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.6 | – | |
| – | 19 | – | – | 15 | – | 12 | – | 39 | 39 | 37 | 0.0 | 31 | 31 | 25 | 20 | 20 | 17 | 12 | 12 | 22 | 22 | |
| – | -16 | – | -21 | -21 | -26 | -26 | – | -27 | -27 | -29 | 0.0 | -35 | -35 | -42 | -47 | -47 | -51 | -56 | -60 | -63 | -63 | |
| 18 | 18 | 14 | – | 15 | – | 15 | – | 18 | 15 | 18 | 18 | 18 | 18 | 18 | 0.0 | 18 | 18 | 18 | 19 | 23 | 21 |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.